Table 1.
Evaluation of promotional literature as per WHO criteria (n = 513)
| Criteria | Mentioned number (%) |
|---|---|
| INNa | 492 (95.9) |
| Brand name | 513 (100) |
| Contentb | 408 (79.5) |
| Adjuvant | 10 (1.9) |
| Approved therapeutic use/sc | 443 (86.3) |
| Dosage form | 447 (87.1) |
| Regimend | 165 (32.2) |
| Safety information | 45 (8.8) |
| Manufacturer address | 362 (70.6) |
| References to scientific information | 316 (61.6) |
a
International nonproprietary name,
b
Active drug per dosage form,
c
Drug use approved as per Central Drugs Standard Control Organization (CDSCO),
d
Drug dose, frequency, and duration of drug